These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10680)

  • 1. [Effect of Fendilin on the exercise test in patients with coronary disease].
    Spiel R; Enenkel W
    Wien Med Wochenschr; 1976 Mar; 126(13-14):186-9. PubMed ID: 10680
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
    Reiterer W
    Wien Med Wochenschr; 1980 Dec; 130(23):772-7. PubMed ID: 6111161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of coronary insufficiency with a combination of a coronary dilator and a beta-adrenergic blockader].
    Grujić M; Perinović M
    Med Arh; 1972; 26(4):267-70. PubMed ID: 4405711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ergometric study of the association of a beta-blocker and a nitrate derivative].
    Jullien G
    Nouv Presse Med; 1978 Sep; 7(31):2727-31. PubMed ID: 30951
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
    Bonelli J; Gazo F; Liedtke RK
    Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New drug (Sensit) for the treatment of coronary disease in a double blind test].
    Pillen D
    Fortschr Med; 1974 Jun; 92(16):709-11. PubMed ID: 4600940
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of beta sympatholytic agent ICI 50172 (Dalzic) in various cardiovascular diseases].
    Müller H; Barthels F; Kluthe R
    Med Klin; 1973 May; 68(19):634-41. PubMed ID: 4125216
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stress studies of patients with coronary insufficiency receiving a beta blockader with reference to the beta-sympathicolytic blood level behavior].
    Otten H; Gugler R; Bodem G
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1735-8. PubMed ID: 347798
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of psycho-neurotic conversion reactions with pindolol. (Effect on cardio-vascular response to exercise).
    Kelesidis G; Hagis P; Samaras C
    Indian Heart J; 1972 Jun; 24():Suppl 1:238-43. PubMed ID: 4147280
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current problems in the conservative long-term treatment of ischemic heart disease].
    Urbaszek W; Modersohn D; Schauer J; Günther K
    Z Arztl Fortbild (Jena); 1976 Jan; 70(1):2-13. PubMed ID: 9744
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ergometric evaluation of the cardioprotective effect of pindolol in coronary disease. Comparison of 2 galenic forms].
    Mérier GR; Perrenoud JJ
    Schweiz Med Wochenschr; 1988 Jul; 118(26):1016-20. PubMed ID: 3413461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular drugs: effects on exercise testing and exercise training of the coronary patient.
    Wenger NK
    Cardiovasc Clin; 1985; 15(2):133-43. PubMed ID: 2868791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of beta adrenergic blockaders on the effort test in coronary insufficiency].
    Demiroglu C; Oztürk M
    Presse Med (1893); 1971 Apr; 79(17):765-6. PubMed ID: 4396515
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
    Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
    Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary reserve and cardiac output of patients with ischemic heart disease after measured exercise therapy as well as additional treatment with hexobendine].
    Drews A
    Arzneimittelforschung; 1968 Aug; 18(8):1084-94. PubMed ID: 5755843
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carbochromen in therapy of acute and chronic coronary insufficiency].
    Votcal BE; Lozinskij LG
    Arzneimittelforschung; 1970 Mar; 20():459-60. PubMed ID: 4989254
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coronary dilators].
    Ilic-Vukotić M
    Med Arh; 1972; 26(2):81-4. PubMed ID: 4402269
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of beta blockaders in arrhythmias and ischemic heart disease].
    Rosselot E
    Rev Med Chil; 1982 Dec; 110(12):1224-32. PubMed ID: 6135249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.